Skip to content

An electronic nose in the intensive care investigation of acute lung injury and acute respiratory distress syndrome.

An electronic nose in the intensive care investigation of acute lung injury and acute respiratory distress syndrome.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON27329
Enrollment
150
Registered
2008-11-24
Start date
2008-12-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ALI, ARDS, eNOSE, sepsis, mechanical ventilation. ALI, ARDS, eNOSE, sepsis, beademing.

Interventions

No interventions, diagnostic study.

Sponsors

Academic Medical Center (AMC), Departments of Pulmonology and Intensive Care.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients with established ALI/ARDS according to the American/European Consensus Criteria 2. Patients at risk for developing ALI/ARDS 3. Patients without lung injury, not at risk for developing ALI/ARDS and not known to a have pre-existent pulmonary condition

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years of age 2. Pregnancy 3. Current malignancy 4. Use of steroids in higher than hysiologic dosages (300 mg hydrocortisone or equivalent) 5. Recent cardiopulmonary surgery (reason for admittance)

Design outcomes

Primary

MeasureTime frame
Electronic nose smellprint. Exhaled air is collected via a connector in the circuit of the mechanical ventilator near the tube and, if present, proximal to the filter. The connector is attached to the electronic nose (Cyranose 320) and measurements are taken for 60 seconds. When exposed to a gas mixture, the sensors of the electronic nose will swell and thus change the electrical conductance, resulting in a unique smellprint.

Secondary

MeasureTime frame
- Lung injury score.

Contacts

Public ContactNiki Fens

Clinical Research Fellow 'Electronic Nose' Academic Medical Center (AMC) University of Amsterdam Department of Pulmonology F5-260 P.O.Box 22660

N.Fens@amc.nl+31 (0)20 5664359

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)